Physician profile
Edwin Colon
NPI 1891742227
$767.03
in general payments reported to CMS, 2019-2025
16 companies · $52.91 in 2025
The $52.91 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $105 · 2021: $228 · 2022: $98.74 · 2023: $50.62 · 2025: $52.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $108.87 | 2019-2023 | Xtampza |
| Abbott Laboratories | $103.64 | 2019-2023 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.53 | 2019-2023 | Relistor |
| Medtronic USA, INC. | $76.47 | 2020 | |
| Boston Scientific Corporation | $67.85 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $47.40 | 2019-2020 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Grt US Holding, INC. | $45.00 | 2021 | |
| Biodelivery Sciences International, INC. | $44.13 | 2019-2021 | |
| Abbvie INC. | $35.79 | 2021 | |
| Daiichi Sankyo INC. | $32.05 | 2019 | |
| Medtronic, INC. | $14.62 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.42 | 2019 | |
| Nevro Corp. | $13.62 | 2022 | |
| Shionogi INC | $13.44 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.